(Reuters) -Amgen will test its obesity drug candidate in patients at risk of weight-related conditions such as heart, liver and kidney diseases in its late-stage trial, the company's CEO Robert ...

Add Yahoo as a preferred source to see more of our stories on Google. More than 2 out of 5 adults in the U.S. are considered obese, according to the Centers for Disease Control and Prevention. But ...

The future is uncertain — but your kid’s waistline as an adult might not be. Scientists have developed a groundbreaking test that can identify children as young as five who are at increased risk of ...

The new tool could help predict obesity-related health risks earlier and reshape prevention strategies, researchers say. The ...

What if we could prevent people from developing obesity? The World Obesity Federation expects more than half the global population to develop overweight or obesity by 2035. However, treatment ...

A genetic test may one day predict a child’s risk of obesity in adulthood, paving the way for early interventions. Certain genetic variants can affect how a person’s body stores fat or make them more ...

Taken on its own, the number is astonishing. According to the CDC, as of August 2023, 40.3 percent of U.S. adults—some 100 million people—met the clinical definition for obesity. But this same ...